A01K 2207/20
Animals treated with compounds which are neither proteins nor nucleic acids
A01K2207/20 (Animals treated with compounds which are neither proteins nor nucleic acids) appears on 75 US grants and 217 published applications in this corpus.
Search patents in A01K- Granted patents
- 75
- Published applications
- 217
- Assignees
- 159
- Inventors
- 527
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 2 | 5 |
| 2011 | 0 | 5 |
| 2012 | 2 | 6 |
| 2013 | 2 | 6 |
| 2014 | 2 | 5 |
| 2015 | 5 | 8 |
| 2016 | 2 | 8 |
| 2017 | 5 | 9 |
| 2018 | 3 | 13 |
| 2019 | 4 | 10 |
| 2020 | 8 | 19 |
| 2021 | 8 | 20 |
| 2022 | 7 | 30 |
| 2023 | 6 | 22 |
| 2024 | 8 | 16 |
| 2025 | 8 | 17 |
| 2026 | 3 | 11 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Application of TPK as a target in Alzheimer's disease17 Mar 2026US 12,575,549 B2Shanghai Raising Pharmaceutical Co., Ltd.
- Proteins with cardioprotective activity10 Mar 2026US 12,569,574 B2International Centre for Genetic Engineering and Biotechnology (Icgeb)
- Gene therapies for lysosomal disorders10 Mar 2026US 12,570,963 B2Prevail Therapeutics, Inc.
- Composition comprising MLS-STAT3 for prevention or treatment of immune disease9 Dec 2025US 12,492,233 B2The Catholic University of Korea Industry-Academic Cooperation Foundation
- Porous hollow fiber membrane and methods of using it to select immune checkpoint inhibitor18 Nov 2025US 12,474,325 B2Taipei Medical University
- Organ regeneration method utilizing blastocyst complementation3 Sep 2026US 2026/0256122 A1The University of Tokyo
- Methods and materials for treating gastrointestinal disorders27 Aug 2026US 2026/0248863 A1Mayo Foundation for Medical Education and Research
- Utilization of a hibernation-like state in neurological diseases27 Aug 2026US 2026/0248961 A1Okinawa Institute of Science and Technology School Corporation
- Methods and pharmaceutical compositions for the treatment of fibrosis with agents capable of inhibiting the activation of mucosal-associated invariant t (mait) cells23 Jul 2026US 2026/0209360 A1Assistance Publique-Hopitaux de Paris
- Gene therapies for lysosomal disorders18 Jun 2026US 2026/0167941 A1Prevail Therapeutics, Inc.
Most cited
By later US patents
- Compositions for treating pathological calcification conditions, and methods using same15US 10,064,917 B2Yale Unviersity · 2018
- Compositions for treating pathological calcification conditions, and methods using same15US 10,517,927 B2Yale University · 2019
- Pathological animal model for pelvic pain syndrome15US 8,426,673 B2Astellas Pharma Inc. · 2013
- Chemical inhibitors of inhibitors of differentiation12US 8,138,356 B2Angiogeney, Inc. · 2012
- Compositions for treating pathological calcification conditions, and methods using same11US 10,583,170 B2Yale University · 2020